Atrial electrical remodeling induced by chronic ischemia and inflammation in patients with stable coronary artery

Răzvan Constantin Serban1, Alkora Ioana Balan2, Marcel Perian2

  • 1Department of Physiology, University of Medicine and Pharmacy of Tîrgu Mureş; Laboratory of Cardiac Catheterization, Angiography and Electrophysiology, Emergency Institute for Cardiovascular Diseases and Transplantation, Tîrgu Mureş, Romania.

Insights

Chronic inflammation in coronary artery disease patients alters atrial electrophysiology, increasing arrhythmia risk. This study links inflammatory markers to changes in atrial depolarization, suggesting a pro-arrhythmic effect.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Inflammation Research

Background:

  • Coronary artery disease (CAD) pathophysiology involves chronic inflammation.
  • Inflammation is linked to myocardial remodeling and atrial arrhythmia vulnerability.
  • The effect of chronic inflammation on atrial electrophysiology in CAD patients is not well understood.

Purpose of the Study:

  • To investigate the impact of low-grade chronic inflammation on atrial electrophysiology.
  • To assess atrial electrical properties in stable CAD patients undergoing coronary artery bypass grafting (CABG).

Main Methods:

  • Measured circulating inflammatory, angiogenesis, and endothelial dysfunction markers in 30 CAD patients pre-CABG.
  • Collected right atrial appendage samples during CABG.
  • Performed atrial action potential recordings using microelectrode technique in six patients.

Main Results:

  • Interleukin (IL)-1b, IL-6, vascular endothelial growth factor (VEGF), and hemoglobin levels positively correlated with atrial depolarization duration.
  • IL-6, VEGF, and hemoglobin levels negatively correlated with atrial depolarization velocity.
  • No significant correlation found between markers and other action potential parameters.

Conclusions:

  • Chronic inflammation and ischemia in CAD patients are associated with pro-arrhythmic atrial electrical remodeling.
  • These electrophysiological changes may increase the risk of postoperative atrial arrhythmias after CABG.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
958
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
409
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
238
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
622
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
358
Inflammation01:38

Inflammation

Overview
61.9K